Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Thomson, Alex ^a   Maltezos, Stefanos ^a   Paliokosta, Elena ^a   Xenitidis, Kiriakos ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b BETHLEM ROYAL HOSPITAL   (United Kingdom)

Author keywords

Amphetamine *therapeutic use ; Attention deficit disorder with hyperactivity *drug therapy ; Central nervous system stimulants *therapeutic use ; Child; Child, preschool; Fragile X syndrome complications ; Humans; Mentally disabled persons *psychology ; Methylphenidate therapeutic use

Indexed keywords

AMPHETAMINE; DEXAMPHETAMINE; METHYLPHENIDATE; PLACEBO; PSYCHOTROPIC AGENT; RISPERIDONE;

ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITION; DRUG EFFICACY; DRUG TOLERABILITY; FRAGILE X SYNDROME; HUMAN; INTELLECTUAL IMPAIRMENT; IRRITABILITY; MENTAL DEFICIENCY; MENTAL INSTABILITY; META ANALYSIS; MORNING DOSAGE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; ADULT; CHILD; MENTAL PATIENT; PSYCHOLOGICAL ASPECT;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; HUMANS; MENTALLY DISABLED PERSONS; PSYCHOTROPIC DRUGS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISPERIDONE;

EID: 70249144652     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007009.pub2     Document Type: Review

References (103)

1. * Hagerman RJ, Murphy MA, Wittenberger MD. A Controlled Trial of Stimulant Medication in Children with the Fragile-X Syndrome. American Journal of Medical Genetics 1988;30(1-2):377-392. [: 0148-7299]
2. Alexandris A, Lundell FW. Effect of thioridazine, amphetamine and placebo on the hyperkinetic syndrome and cognitive area inmentally deficient children. Canadian Medical Association Journal 1968;98(2):92-96.
3. Anton A, Greer M. Dextroamphetamine, catecholamines, and behavior. Archives of Neurology 1969;21:248-252.
4. Barcai A. Predicting the response of children with learning disabilities and behavior problems to dextroamphetamine sulfate. The clinical interview and the finger twitch test. Pediatrics 1971;47(1):73-80.
5. Berkson G. Stereotyped movements of mental defectives: VI. No effect of amphetamine or a barbiturate. Perceptual and Motor Skills 1965;21:698.
6. * Broomand I. The Effect of Dexedrine on the learning and performance of brain-damaged hyperactive mental retardates (MSc Thesis). Pittsburg: Kansas State College of Pittsburg, 1967.
7. Burgio L, Page T, Capriotti R. Clinical behavioral pharmacology: methods for evaluating medications and contingency management. Journal of Applied Behaviour Analysis 1985;18:45-59.
8. Comly HH. Cerebral stimulants for children with learning disorders?. Journal of Learning Disabilities 1971;4(9):484-490. [: 0022-2194]
9. Conners CK, Eisenberg L, Barcai A. Effect of dextroamphetamine on children. Studies on subjects with learning disabilities and school behavior problems. Archives of General Psychiatry 1967;17(4):478-485
10. Conners CK, Rothschild G, Eisenberg L, Schwartz LS, Robinson E. Dextroamphetamine sulfate in children with learning disorders. Effects on perception, learning, and achievement. Archives of General Psychiatry 1969;21(2):182-190
11. Craft M. Mental disorder in the defective: the use of tranquilizers. American Journal of Mental Deficiency 1959;64:63-71.
12. Cutler M, Little J, Strauss A. The effect of Benzedrine on mentally deficient children. American Journal of Mental Deficiency 1940;45:59-65.
13. Denhoff E, Davids A, Hawkins R. Effects of dextroamphetamine on hyperkinetic children: A controlled double blind study. Journal of Learning Disabilities 1971;. 4(9):491-498. [: 0022-2194]
14. Eaton M, Sells CJ, Lucas B. Psychoactive medication and learning disabilities. Journal of Learning Disabilities 1977;10(7):403-410. [: 0022-2194]
15. Eisenberg L, Lachman R, Molling P, Lockner A, Mizelle J, Conners C. Psychopharmacologic Experiment in a Training School for Delinquent Boys: Methods, Problems, Findings. American Journal of Orthopsychiatry 1963;33:431.
16. Faraone SV, Pliszka SR, Olvera RL, Skolnik R, Biederman J. Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: A reanalysis using drug-placebo and drug-drug response curve methodology. Journal of Child and Adolescent Psychopharmacology 2001;11(2):171-180. [: 1044-5463] (Pubitemid 32588489)
17. Faraone SV, Short EJ, Biederman J, Findling RL, Roe C, Manos MJ. Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study. International Journal of Neuropsychopharmacology 2002;5(2):121-129. [: 1461-1457] (Pubitemid 34662974)
18. Fish C, Bowling E. Effect of amphetamine on speech defects in the mentally retarded. California Medicine 1962;96:109-111.
19. Geller B, Guttmacher L, Bleeg M. Coexistence of childhood onset pervasive developmental disorder and attention-deficit disorder with hyperactivity. American Journal of Psychiatry 1981;138:388-389.
20. Gittelman-Klein R, Abikoff H, Pollack E, Katz, Mattes. Controlled trial of behaviour modification and methylphenidate in hyperactive children. In: Whalen C, Henker B editor(s). Hyperactive Children: The Social Ecology of Identification and Treatment. New York: Academic Press, 1980.
21. Hagerman R, Jackson C, Amiri K, Silverman A, O'Connor R, Sobesky W. Girls with fragile X syndrome: physical and neurocognitive status and outcome. Pediatrics 1992;89:395-400.
22. Helsel W, Hersen M, Lubetsky J. Stimulant medication and the retarded. Journal of the American Academy of Child and Adolescent Psychiatry 1989;28:138-139.
23. LobbH. TraceGSR conditioning with Benzedrine inmentally defective and normal adults. American Journal of Mental Deficiency 1968;73:239-246.
24. McConnell TR, Jr, Cromwell RL, Bialer I, Son CD. Studies in activity level: VII. Effects of amphetamine drug administration on the activity level of retarded children. American Journal of Mental Deficiency 1964;68(5):647-651. [: 0002-9351]
25. Molitch M, Eccles J. Effect of benzedrine sulfate on the intelligence scores of children. American Journal of Psychiatry 1937;94:587-590.
26. Molitch M, Sullivan J. Effect of benzedrine sulfate on children taking New Stanford Achievement Test. American Journal of Orthopsychiatry 1937;7:519-522.
27. Morris J, MacGillivary R, Mathieson C. The results of the experimental administration of amphetamine sulfate in oligophrenia. Journal of Mental Science / British Journal of Psychiatry 1955;101:131-140.
28. Moskowitz H. Benzedrine therapy for the mentally handicapped. American Journal of Mental Deficiency 1941;45:540-543.
29. Ounsted C. The hyperkinetic syndrome in epileptic children. Lancet 1955;266:303-311.
30. Payton JB, Burkhart JE, Hersen M, Helsel WJ, Payton JB, Burkhart JE, Hersen M, Helsel WJ. Treatment of ADDH in mentally retarded children: a preliminary study. Journal of the American Academy of Child & Adolescent Psychiatry 1989;28(5):761-767 (Pubitemid 19239930)
31. Schmidt K. The Effect of Stimulant Medication in Childhood-Onset Pervasive Developmental Disorder - a Case-Report. Journal of Developmental and Behavioral Pediatrics 1982;3(4):244-246. [: 0196-206X] (Pubitemid 13188059)
32. Sprague R, Werry J, Scott K. Effects of dextroamphetamine on activity level and learning in retarded children. Meeting of the Midwestern Psychological Association. Chicago, 1967.
33. Steinberg GG, Troshinsky C, Steinberg HR. Dextroamphetamine-responsive behavior disorder in school children. American Journal of Psychiatry 1971;. 128(2):174-179. [: 0002-953X]
34. Sulzbacher S. Behavior analysis of drug effects in the classroom. In: Semb G editor(s). Behavior analysis and education. Lawrence: University of Kansas, 1972:37-52.
35. Swanson JM, Cantwell D, Lerner M, McBurnett K, Hanna G. Effects of stimulant medication on learning in children with ADHD. Journal of Learning Disabilities 1991;24(4):219-230
36. Volkmar F, Hoder E, Cohen D. Inappropriate use of stimulant medications. Clinical Pediatrics 1985;24:127-130
37. Zrull JP, Westman JC, Arthur B, Bell WA. A Comparison of Chlordiazepoxide, D-Amphetamine, and Placebo in the Treatment of the Hyperkinetic Syndrome in Children. American Journal of Psychiatry 1963;120:590-591
38. Aman MG, Singh NN, Stewart AW, Field CJ. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency 1985;89:485-491.
39. Aman MG, Kern RA, McGhee DE, Arnold LE. Fenfluramine and methylphenidate in children with mental retardation and ADHD: clinical and side effects. Journal of the American Academy of Child & Adolescent Psychiatry 1993;32(4):851-859.
40. Aman M. Stimulant drugs in the developmental disabilities revisited. Journal of Developmental and Physical Disabilities 1996;8(4):347-365 (Pubitemid 126723650)
41. Aman MG, Armstrong S, Buican B, Sillick T. Four year follow-up of children with low intelligence and ADHD: a replication. Research in Developmental Disabilities 2002;23:119-134. (Pubitemid 34308895)
42. Antshel K, Phillips M, Gordon M, Barkley R. Is ADHD a valid disorder in children with intellectual delays?. Clinical Psychology Review 2006;26(5):555-572. (Pubitemid 44233092)
43. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd Edition. American Psychiatric Publishing, 1987.
44. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. American Psychiatric Publishing, 2000.
45. Arscott K, Dagnan D, Stenfert Kroese B. Assessing the Ability of People with a Learning Disability to Give Informed Consent to Treatment. Psychological Medicine 1999;29:1367-1375
46. Barkley RA. Hyperactive Children: a Handbook for Diagnosis and Treatment. New York: Guildford Press, 1981.
47. Barkley RA. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York: Guildford Press, 1990.
48. Barkley RA. The ecological validity of laboratory and analogue assessment methods of ADHD symptoms. Journal of Abnormal Child Psychology 1991;19(2):149-178
49. Barkley RA, Murphy KR. Attention Deficit Hyperactivity Disorder: a Clinical Workbook. The Guildford Press, 2006.
50. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of depression. Chichester: John Wiley, 1979.
51. Beck AT, Epstein N, Brown G, Steer R. An Inventory for Measuring Clinical Anxiety: Psychometric Properties. Journal of Consulting and Clinical Psychology 1988;56(6):893-897. (Pubitemid 19008360)
52. Bramble D. Stimulants and British learning disability psychiatrists. Journal of Applied Research in Intellectual Disabilities 1999;12:157-163
53. Cleary PD, Jette AJ. Reliability and validity of the Functional Status Questionnaire. Quality of Life Research 2000;9:747-753.
54. Collin C, Wade DT, Davies S, Horne V. The Barthel ADL Index: a reliability study. International Disability Studies 1988;10:61-63. (Pubitemid 18159441)
55. Conners CK. Rating scales for use in drug studies with children (Special Issue: Pharmacotherapy of children). Psychopharmacology Bulletin 1973;9(special issue):24-84.
56. Dekker MC, Koot HM. DSM-IV Disorders in Children With Borderline to Moderate Intellectual Disability I: Prevalence and Impact. Journal of the American Academy of Child & Adolescent Psychiatry 2003;42(8):916-922.
57. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale - preliminary report. Psychopharmacology Bulletin 1973;9(1):13-28.
58. Einfeld SL, Tonge BJ. The Developmental Behavior Checklist: the development and validation of an instrument to assess behavioral and emotional disturbance in children and adolescents with mental retardation. Journal of Autism & Developmental Disorders 1995;25(2):81-104.
59. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31:140-149. (Pubitemid 34284916)
60. Fawcett S. Symptoms, signs, side effects checklist. Psychopharmacology Bulletin 1987;23:322-323.
61. Fox RA, Wade EJ. Attention Deficit Hyperactivity Disorder Among Adults with Severe and Profound Mental Retardation. Research in Developmental Disabilities 1998;19(3):275-280. (Pubitemid 28311321)
62. Furukawa TA, Cipriani A, Barbui C, Brambilla P, Watanabe N. Imputing response rates from means and standard deviations in meta-analyses. International Clinical Psychopharmacology 2005;20:49-52. (Pubitemid 40105550)
63. Fyson R, Simons K. Strategies for change: making Valuing People a reality. British Journal of Learning Disabilities 2003;4:153-158 (Pubitemid 37477241)
64. Goodman R. The Strengths and Difficulties Questionnaire: a research note. Journal of Child Psychology and Psychiatry 1997;38:581-586 (Pubitemid 27341892)
65. Gordon M. The Gordon Diagnostic System. New York: Gordon Systems, Inc., 1986.
66. Goyette CH, Conners CK, Ulrich RF. Normative data on the Revised Conners Parent and Teacher Rating Scales. Journal of Abnormal Child Psychology. 1978; Vol.6:221-236.
67. Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology 1959;32:50-55.
68. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960;23:56-62.
69. Handen BL, Janosky J. Long-Term Follow-Up of Children with Mental Retardation/Borderline Intellectual Functioning and ADHD. Journal of Abnormal Child Psychology 1997;25(4):287-295. (Pubitemid 27391286)
70. Hardan A, Sahl R. Psychopathology in Children and Adolescents with Developmental Disorders. Research in Developmental Disabilities 1997;18(5):369-382. (Pubitemid 27418054)
71. Harris P. The Challenging Behaviour Checklist. Bristol: Nora Fry Research Centre, 1990.
72. Hastings RP, Beck A, Daley D, Hill C. Symptoms of ADHD and their correlates in children with intellectual disabilities. Research in Developmental Disabilities 2005;26(5):456-468 (Pubitemid 41317192)
73. Higgins JPT, Green S (eds). APPENDIX 5b: Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. Chichester, UK: John Wiley & Sons, Ltd, 2006.
74. Higgins JPT, Green S (eds). 8.11.3 Cross-over Trials. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. Chichester, UK: John Wiley & Sons, Ltd, 2006.
75. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org Version 5.0.0 [updated February 2008].
76. Jette AM, Davies AR, Cleary PD, Calkins DR, Rubenstein LV, Fink A, Kosecoff J, Young RT, Brook RH, Delbanco TL. The Functional Status Questionnaire: reliability and validity when used in primary care. Journal of General Internal Medicine 1986;1(3):143-149.
77. Jou R, Handen B, Hardan A. Psychostimulant treatment of adults with mental retardation and attention-deficit hyperactivity disorder. Australasian Psychiatry 2004;12(4):376-379. (Pubitemid 40103727)
78. Kadesjo B, Gillberg C. The Comorbidity of ADHD in the General Population of Swedish School-age Children. Journal of Child Psychology & Psychiatry 2001;42(4):487-492. (Pubitemid 32509770)
79. Karnofsky D, Abelmann W, Craver L, Burchenal J. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948;1:634-656.
80. Kovacs M. Children's Depression Inventory Manual. North Tonawanda: Multi-Health Systems, Inc, 1992.
81. Lott IT, McGregor M, Engelman L, Touchette P, Tournay A, Sandman C, Fernandez G, Plon L, Walsh D. Longitudinal prescribing patterns for psychoactive medications in community-based individuals with developmental disabilities: Utilization of pharmacy records. Journal of Intellectual Disability Research 2004;48:563-571 (Pubitemid 39214375)
82. Mahoney FI, Barthel D. Functional evaluation: the Barthel Index. Maryland State Med Journal 1965;14:56-61.
83. Matson JL, Kazdin AE, Senatore V. Psychometric properties of the psychopathology instrument for mentally retarded adults. Applied Research in Mental Retardation 1984;5:81-89
84. Miller ML, Fee VE, Netterville AK. Psychometric properties of ADHD rating scales among children with mental retardation I: Reliability. Research in Developmental Disabilities 2004;25(5):459-476 (Pubitemid 38798129)
85. Miller ML, Fee VE, Jones CJ. Psychometric properties of ADHD rating scales among children with mental retardation II: validity. Research in Developmental Disabilities 2004;25(5):477-492 (Pubitemid 38798130)
86. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979;134:382-389. (Pubitemid 9136500)
87. Montgomery RJV, Stull DE, Borgotta EF. Measurement and the analysis of burden. Research on Aging 1985;7(1):137-152.
88. Moss SC, Prosser H, Ibbotson B, Goldberg DP. Respondent and informant accounts of psychiatric symptoms in a sample of patients with learning disability. Journal of Intellectual Disability Research 1996;40:457-465 (Pubitemid 26362894)
89. National Institute of Mental Health. Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacology Bulletin 1985;21:714-1124.
90. Nutt DJ, Fone K, Asherson P, Bramble D, Hill P, Matthews K, Morris KA, Santosh P, Sonuga-Barke E, Taylor E, Weiss M, Young S. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology (Consensus statement). Cambridge: British Association for Psychopharmacology, 2006.
91. Pfadt A, Tryon WW. Issues in the selection and use of mechanical transducers to directly measure motor activity in clinical settings. Applied Research in Mental Retardation 1983;4:251-270
92. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. American Journal of Psychiatry 2007;164:942-948 (Pubitemid 46972911)
93. The Royal College of Psychiatrists. Challenging Behaviour: A Unified Approach. CR144, 2007.
94. Reiter S, Lapidot-Lefler N. Bullying among special education students with intellectual disabilities: differences in social adjustment and social skills. Intellectual & Developmental Disabilities 2007;45(3):174-181
95. Robertson J, Emerson E, Hatton C, Elliott J, McIntosh B, Swift P, Krinjen-Kemp E, Towers C, Romeo R, Knapp M, Sanderson H, Routledge M, Oakes P, Joyce T. Person-centred planning: factors associated with successful outcomes for people with intellectual disabilities. Journal of Intellectual Disability Research 2007;51(3):232-243 (Pubitemid 46189569)
96. Rojan J, Borthwick-Duffy SA. The association between psychiatric diagnosis and severe behaviour problems in mental retardation. Annals of Clinical Psychiatry 1993;5:163-170.
97. Seeman P, Madras BK. Anti-hyperactivity medication: methylphenidate and amphetamine. Molecular Psychiatry 1998;3:386-396
98. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S. A children's global assessment scale (CGAS). Archives of General Psychiatry 1983;40(11):1228-1231.
99. Strømme P, Diseth TH. Prevalence of psychiatric diagnoses in children with mental retardation: data from a population-based study. Developmental Medicine and Child Neurology 2000;42:266-270. (Pubitemid 30175927)
100. Ullman RK, Sleator EK, Sprague RL. A new rating scale for diagnosis and monitoring of ADD children. PsychopharmacologyBulletin 1984;20:160-163.
101. Ventura MA, Green MF, Shaner A, Liberman RP. Training and quality assurance with the brief psychiatric rating scale: "The drift buster". International Journal of Methods in Psychiatric Research 1993;3:221-244.
102. World Health Organization. The ICD-10 Classification of Mental & Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. 10th Edition. Geneva: World Health Organization, 1992.
103. Wong JG, Clare ICH, Holland AJ, Watson PC, Gunn M. The capacity of people with a "mental disability" to make a health care decision. Psychological Medicine 2000;30(2):295-306.